Impact of dance therapy on the psychophysical well-being of wheelchair-bound cancer patients in palliative care

Evaluation of the effects of dance therapy on psychophysical aspects of wheelchair-bound cancer patients in advanced stages undergoing palliative care: a randomized controlled trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN15797505

Enrollment

Registered

2024-12-10

Start date

2025-01-14

Completion date

Unknown

Last updated

2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wheelchair-bound cancer patients in advanced stages undergoing palliative care Cancer

Interventions

For dance therapy intervention, patients included in the study will be randomly assigned to two groups by drawing one of two cards with the inscriptions "experimental group" (EG) and "control group" (

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Social Society Cordis Hospice patient 2. Diagnosis of advanced cancer 3. Completed causal treatment 4. Wheelchair-bound patient 5. Provided informed consent to participate in the study 6. Scoring above 20 points on the 100-point Barthel Index assessing independence in daily activities 7. Scoring above 23 points on the Mini-Mental State Examination (MMSE) assessing cognitive functions

Exclusion criteria

Exclusion criteria: 1. Central nervous system tumors 2. Internal and external bleeding 3. Dangerous heart arrhythmia 4. Unstable hypertension 5. Acute phlebitis or deep vein thrombosis 6. Acute respiratory failure 7. Intestinal obstruction 8. Vomiting, diarrhea (within the last 24-36 hours) 9. Inflammatory processes in the abdominal cavity, during and after radiotherapy (up to 6 weeks after abdominal radiation) 10. Infection requiring antibiotic therapy 11. Age <18 years 12. Inability to understand the Polish language, both spoken and written

Design outcomes

Primary

Measure	Time frame
1. Level of anxiety and depression will be measured using the Hospital Anxiety and Depression Scale (HADS), Polish version, at baseline, after 4 and 8 weeks of the intervention, and 4 weeks after its completion. 2. Pain intensity will be measured using the Visual Analogue Scale (VAS) at baseline, after 4 and 8 weeks of the intervention, and 4 weeks after its completion. 3. Fatigue will be measured using the Fatigue Assessment Scale (FAS), Polish version, at baseline, after 4 and 8 weeks of the intervention, and 4 weeks after its completion. 4. Quality of life will be measured using the Edmonton Symptom Assessment System (ESAS-r), Polish version, at baseline, after 4 and 8 weeks of the intervention, and 4 weeks after its completion.	—

Measure

Time frame

1. Level of anxiety and depression will be measured using the Hospital Anxiety and Depression Scale (HADS), Polish version, at baseline, after 4 and 8 weeks of the intervention, and 4 weeks after its completion. 2. Pain intensity will be measured using the Visual Analogue Scale (VAS) at baseline, after 4 and 8 weeks of the intervention, and 4 weeks after its completion. 3. Fatigue will be measured using the Fatigue Assessment Scale (FAS), Polish version, at baseline, after 4 and 8 weeks of the intervention, and 4 weeks after its completion. 4. Quality of life will be measured using the Edmonton Symptom Assessment System (ESAS-r), Polish version, at baseline, after 4 and 8 weeks of the intervention, and 4 weeks after its completion.

—

Secondary

Measure	Time frame
1. Independence in daily activities will be measured using a 100-point Barthel Scale at the stage of qualifying patients for the study and after 8 weeks of the intervention. 2. Cognitive function will be measured using the Mini-Mental State Examination (MMSE), Polish version, at the stage of qualifying patients for the study and after 8 weeks of the intervention.	—

Countries

Poland

Contacts

Public ContactAgnieszka Opala-Berdzik

a.opala-berdzik@awf.katowice.pl+48 (0)322075301

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026